Johnson & Johnson (JNJ) Q4 Earnings - Check Out The Amazing Technical Setup!

TL;DR

Johnson and Johnson's earnings were impacted by foreign exchange and vaccine-related challenges, but the company's cost control measures and diverse portfolio make it an attractive investment for portfolios lacking healthcare exposure.

Transcript

what is going on investors hopefully you guys are doing well out there time to keep earnings season moving right along this time we're going to take a look at Johnson and Johnson might be the first time here on the channel that we'll take a look at the stock ticker symbol J and J over the last year stocks up three percent considering this whole sto... Read More

Key Insights

• 🎭 Johnson and Johnson's stock has performed well despite market downturns, demonstrating its resilience and stability.
• ☠️ The company's revenue was impacted by foreign exchange rates and increased competition from other vaccine producers.
• 👻 Johnson and Johnson's acquisition strategy allows them to access new products and technologies, providing growth opportunities.
• 🎮 Cost control measures have helped the company maintain profitability, despite revenue declines.
• 🖤 Johnson and Johnson's diverse portfolio makes it a valuable addition to portfolios lacking exposure to the healthcare sector.
• 🎚️ The stock's technical analysis suggests a potential buying opportunity at current levels, with support around $155 to $160.
• 🦺 While Johnson and Johnson may not outperform the S&P 500, it provides diversification and a margin of safety for portfolios aiming to outperform the market.

Questions & Answers

Q: How has Johnson and Johnson's stock performed compared to the overall market?

Johnson and Johnson's stock has performed well, with a total return of 3% over the last year, despite the market downturn.

Q: What factors have impacted Johnson and Johnson's revenue?

Johnson and Johnson's revenue was impacted by foreign exchange rates and competition from other vaccine producers, leading to a decline in revenue.

Q: How does Johnson and Johnson acquire new products and technologies?

Johnson and Johnson acquires smaller biotech companies to gain access to new products and technologies, allowing them to diversify their portfolio and drive long-term growth.

Q: Why should investors consider adding Johnson and Johnson to their portfolios?

Johnson and Johnson's diverse portfolio and ability to navigate challenges make it an attractive investment for portfolios lacking healthcare exposure. Additionally, their cost control measures and acquisition strategy provide potential for future growth.

Summary & Key Takeaways

• Johnson and Johnson's stock has performed well over the last year, with a total return of 3% despite the overall market decline.

• The company faced challenges due to foreign exchange rates and competition from other vaccine producers, leading to a decline in revenue.

• Johnson and Johnson's ability to acquire smaller biotech companies and its diverse portfolio make it a valuable addition to portfolios lacking healthcare exposure.